HONG KONG – As part of the efforts to reform its drug registration system, China has decided to pilot a marketing authorization holders (MAH) system that allows individuals and research institutes to market drugs.
HONG KONG – To tackle the high prevalence of cholangiocarcinoma in South Korea, two companies have come together in a co-development deal to bring the first treatment to the country.
HONG KONG – To tackle the high prevalence of cholangiocarcinoma in South Korea, two companies have come together in a co-development deal to bring the first treatment to the country.
HONG KONG – In back-to-back deals involving a total of $735 million in up-front cash, French pharma major Sanofi SA is collecting more diabetes drugs for its pipeline, aiming to mitigate the impact on its diabetes business, which has seen a 6.6 percent decline in the global market.
HONG KONG – As part of the efforts to reform its drug registration system, China has decided to pilot a marketing authorization holders (MAH) system that allows individuals and research institutes to market drugs.
HONG KONG – Sichuan-based Revotek Co., a Chinese company claiming to be the first in the world able to produce blood vessels using 3-D bioprinting technology, said it is now planning to combine the technology with a cloud-computing platform.
HONG KONG – Start-up antibody-focused Mabspace Biosciences Co. Ltd. has secured $15 million in series A financing with Lilly Asia Ventures to help move two of its cancer candidates into clinical studies and further its antibody pipeline.
HONG KONG – Celltrion Inc. had a seven-year partnership with Pfizer Inc.'s new subsidiary, Hospira Inc., to develop two biosimilar assets, but those ties were severed last week when Pfizer cut loose the rights for the two assets, saying that it plans to focus on a pipeline of in-house developed biosimilars.
HONG KONG – Sichuan-based Revotek Co., a Chinese company claiming to be the first in the world able to produce blood vessels using 3-D bioprinting technology, said it is now planning to combine the technology with a cloud-computing platform.
